Antidepressant withdrawal reactions

American Family Physician

Volumn 56, Issue 2, 1997, Pages 455-462

  Wolfe, Robert M ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; ATROPINE; BELLADONNA ALKALOID; BENZATROPINE MESILATE; CHOLINERGIC RECEPTOR; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLOMIPRAMINE; CLONAZEPAM; DIMENHYDRINATE; DIPHENHYDRAMINE; FLUOXETINE; FLUVOXAMINE MALEATE; HYDROXYZINE; HYOSCYAMINE; LORAZEPAM; MECLOZINE; PAROXETINE; PROPRANOLOL; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; TRIHEXYPHENIDYL; VENLAFAXINE;

ADULT; AKATHISIA; ANTICHOLINERGIC EFFECT; CASE REPORT; DEPRESSION; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MOOD; MOTOR DYSFUNCTION; ORAL DRUG ADMINISTRATION; REBOUND; REVIEW; SLEEP DISORDER; SUBLINGUAL DRUG ADMINISTRATION; WITHDRAWAL SYNDROME;

ADULT; AMITRIPTYLINE; ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; CLOMIPRAMINE; CYCLOHEXANOLS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MONOAMINE OXIDASE INHIBITORS; SEROTONIN UPTAKE INHIBITORS; SUBSTANCE WITHDRAWAL SYNDROME; TRAZODONE;

EID: 0030793586     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (50)

1. Fyer AJ, Liebowitz MR, Gorman JM, Campeas R, Levin A, Davies SO, et al. Discontinuation of alprazolam treatment in panic patients. Am J Psychiatry 1987;144:303-8.
2. Dilsaver SC, Greden JF. Antidepressant withdrawal phenomena. Biol Psychiatry 1984;19:237-56.
3. Lawrence JM. Reactions to withdrawal of antidepressants, antiparkinsonian drugs, and lithium. Psychosomatics 1985;26:869-74,877.
4. Law W III, Petti TA, Kazdin AE. Withdrawal symptoms after graduated cessation of imipramine in children. Am J Psychiatry 1981;138:647-50.
5. Geller B, Cooper TB, Carr LG, Warham JE, Rodriguez A. Prospective study of scheduled withdrawal from nortriptyline in children and adolescents. J Clin Psychopharmacol 1987;7:252-4.
6. Webster PA. Withdrawal symptoms in neonates associated with maternal antidepressant therapy. Lancet 1973;2(824):318-9.
7. Eggermont E. Withdrawal symptoms in neonates associated with maternal imipramine therapy. Lancet 1973;2(830):680.
8. Cooper GL. The safety of fluoxetine: an update. Br J Psychiatry Suppl 1988;153:77-86.
9. Stoukides JA, Stoukides CA. Extrapyramidal symptoms upon discontinuation of fluoxetine [Letter]. Am J Psychiatry 1991;148:1263.
10. Berlin CS. Fluoxetine withdrawal symptoms [Letter]. J Clin Psychiatry 1996;57:93-4.
11. Einbinder E. Fluoxetine withdrawal? [Letter] Am J Psychiatry 1995;152:1235.
12. Ellison JM. SSRI withdrawal buzz [Letter]. J Clin Psychiatry 1994;55:544-5.
13. Black DW, Wesner R, Gabel J. The abrupt discontinuation of fluvoxamine in patients with panic disorder. J Clin Psychiatry 1993;54:146-9.
14. Mallya G, White K, Gunderson C. Is there a serotonergic withdrawal syndrome? [Letter]. Biol Psychiatry 1993;33:851-2.
15. Szabadi E. Fluvoxamine withdrawal syndrome [Letter]. Br J Psych 1992;60:283-4.
16. Barr LC, Goodman WK, Price LH. Physical symptoms associated with paroxetine discontinuation [Letter]. Am J Psychiatry 1994;151:289.
17. Phillips SD. A possible paroxetine withdrawal syndrome [Letter]. Am J Psychiatry 1995;152:645-6.
18. Pyke RE. Paroxetine withdrawal syndrome [Letter]. Am J Psychiatry 1995;152:149-50.
19. Keuthen NJ, Cyr P, Ricciardi JA, Minichiello WE, Buttolph ML, Jenike MA. Medication withdrawal symptoms in obsessive-compulsive disorder patients treated with paroxetine [Letter]. J Clin Psychopharmacol 1994;14:206-7.
20. Koopowitz LF, Berk M. Paroxetine induced withdrawal effects. Hum Psychopharmacol 1995;10:147-8.
21. Debattista C, Schatzberg AF. Physical symptoms associated with paroxetine withdrawal [Letter]. Am J Psychiatry 1995;152:1235-6.
22. Bloch M, Stager SV, Braun AR, Rubinow DR. Severe psychiatric symptoms associated with paroxetine withdrawal [Letter]. Lancet 1995;346:57.
23. Oehrberg S, Christiansen PE, Behnke K, Borup AL, Severin B, Soegaard J, et al. Paroxetine in the treatment of panic disorder. A randomised, double-blind placebo-controlled study. Br J Psychiatry 1995;167:374-9.
24. Dominguez RA, Goodnick PJ. Adverse events after the abrupt discontinuation of paroxetine. Pharmacotherapy 1995;15:778-80.
25. Reeves RR, Pinkofsky HB. Lhermitte's sign in paroxetine withdrawal [Letter]. J Clin Psychopharmacol 1996;16:411-2.
26. Landry P, Roy L. Withdrawal hypomania associated with paroxetine [Letter]. J Clin Psychopharmacol 1997;17:60-1.
27. Frost L, Lal S. Shock-like sensations after discontinuation of selective serotonin reuptake inhibitors [Letter]. Am J Psychiatry 1995;152:810.
28. Fava GA, Grandi S. Withdrawal syndromes after paroxetine and sertraline discontinuation [Letter]. J Clin Psychopharmacol 1995;15:374-5.
29. Louie AK, Lannon RA, Ajari LJ. Withdrawal reaction after sertraline discontinuation [Letter]. Am J Psychiatry 1994;151:450-1.
30. Leiter FL, Nierenberg AA, Sanders KM, Stern TA. Discontinuation reactions following sertraline. Biol Psychiatry 1995;38:694-5.
31. Rosenstock HA. Sertraline withdrawal in two brothers: a case report. Int Clin Psychopharmacol 1996;11:58-9.
32. Amsden GW, Georgian F. Orthostatic hypotension induced by sertraline withdrawal. Pharmacotherapy 1996;16:684-6.
33. Theilman SB, Christenbury MM. Hypomania following withdrawal of trazodone [Letter]. Am J Psychiatry 1986;143:1482-3.
34. Montalbetti DJ, Zis AP. Cholinergic rebound following trazodone withdrawal? [Letter]. J Clin Psychopharmacol 1988;8:73.
35. Menza MA. Withdrawal syndrome in a depressed patient treated with trazodone [Letter]. Am J Psychiatry 1986;143:1195.
36. Otani K, Tanaka O, Kaneko S, Ishida M, Yasui N, Fukushima Y. Mechanisms of the development of trazodone withdrawal symptoms. Int Clin Psychopharmacol 1994;9:131-3.
37. Farah A, Lauer TE. Possible venlafaxine withdrawal syndrome [Letter]. Am J Psychiatry 1996;153:576.
38. Benazzi F. Venlafaxine withdrawal symptoms [Letter]. Can J Psychiatry 1996;41:487.
39. Boringa JB, de Jong GM, Touw DJ. [Neonatal withdrawal symptoms following the use of clomipramine during pregnancy]. Ned Tijdschr Geneeskd 1992;136:1473-5.
40. Coupland NJ, Bell CJ, Potokar JP. Serotonin reuptake inhibitor withdrawal. J Clin Psychopharmacol 1996;16:356-62.
41. Lazowick AL, Levin GM. Potential withdrawal syndrome associated with SSRI discontinuation. Ann Pharmacother 1995;29:1284-5.
42. Price JS, Waller PC, Wood SM, MacKay AV. A comparison of the post-marketing safety of four selective serotonin re-uptake inhibitors including the investigation of symptoms occurring on withdrawal. Br J Clin Pharmacol 1996;42:757-63.
43. Richelson E. The pharmacology of antidepressants at the synapse: focus on newer compounds. J Clin Psychiatry 1994;55(Suppl A):34-9.
44. Dilsaver SC. Heterocyclic antidepressant, monoamine oxidase inhibitor and neuroleptic withdrawal phenomena. Prog Neuropsychopharmacol Biol Pyschiatry 1990;14:137-61.
45. Garner EM, Kelly MW, Thompson DF. Tricyclic antidepressant withdrawal syndrome. Ann Pharmacother 1993;27:1068-72.
46. Lipinski JF Jr, Mallya G, Zimmerman P, Pope HG Jr. Fluoxetine-induced akathisia: clinical and theroretical implications. J Clin Psychiatry 1989;50: 339-42.
47. Zubenko GS, Cohen BM, Lipinski JF Jr. Antidepressant-related akathisia. J Clin Psychopharmacol 1987;7:254-7.
48. Dilsaver SC. Antidepressant withdrawal syndromes: phenomenology and pathophysiology. Acta Psychiatr Scand 1989;79:113-7.
49. de Leon J, Stanilla JK, White AO, Simpson GM. Anticholinergics to treat clozapine withdrawal [Letter]. J Clin Psychiatry 1994;55:119-20.
50. Dilsaver SC, Feinberg M, Greden JF. Antidepressant withdrawal symptoms treated with anticholinergic agents. Am J Psychiatry 1983;140:249-51.